| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 50 |
| 1 | METHOTREXATE SODIUM | 36 |
| 2 | METHOTREXATE | 30 |
| 3 | PREDNISONE | 28 |
| 4 | CYCLOPHOSPHAMIDE | 27 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 27 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 27 |
| 7 | IBRUTINIB | 25 |
| 8 | DOXORUBICIN | 22 |
| 9 | ADALIMUMAB | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 5 | 0.0031 |
| 1 | BARICITINIB | 5 | 0.0016 |
| 2 | PIRTOBRUTINIB | 1 | 0.0010 |
| 3 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 4 | QUERCETIN | 1 | 0.0008 |
| 5 | RITUXIMAB-ABBS | 4 | 0.0008 |
| 6 | BENDAMUSTINE HCL | 11 | 0.0007 |
| 7 | ELIGLUSTAT | 1 | 0.0006 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 9 | IFOSFAMIDE FOR INJECTION | 10 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 55 |
| 1 | Corticosteroid [EPC] | 51 |
| 2 | Kinase Inhibitor [EPC] | 33 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 30 |
| 4 | Alkylating Drug [EPC] | 28 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 11 |
| 7 | Interleukin-17A Antagonist [EPC] | 11 |
| 8 | Thalidomide Analog [EPC] | 11 |
| 9 | Aminosalicylate [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 2 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 4 | Antiseptic [EPC] | 1 | 0.0002 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 55 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 28 | 0.0001 |